Court Backs Drug Cos. In Suicide Cases

Law360, New York (April 9, 2008, 12:00 AM EDT) -- The U.S. Court of Appeals for the Third Circuit has ruled that federal guidelines on drug warning labels trump state law in a case involving two people who committed suicide while taking antidepressants.

The families of the deceased sued GlaxoSmithKline and Pfizer under state failure-to-warn laws. Warning labels on Paxil and Zoloft did not include strong enough warnings about the risk of suicide and worsening depression, they said.

In a 2-1 decision, the appeals court rejected that argument Tuesday. It ruled that the drugmakers could not...
To view the full article, register now.